Steven Cohen’s Evommune EVMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.1M Buy
2,434,080
+999,031
+70% +$12M 0.02% 907
2026
Q2
$19.1M Buy
1,435,049
+1,398,472
+3,823% +$32.5M 0.02% 918
2026
Q1
$841K Buy
36,577
+2,193
+6% +$49.6K ﹤0.01% 2865
2025
Q4
$589K Buy
+34,384
New +$646K ﹤0.01% 3157

Other funds holding EVMN

Steven Cohen's EVMN Position: Q3 2026 in Review

Steven Cohen increased its Evommune (EVMN) stake by 70% in Q3 2026, buying an estimated $12M and bringing the position to 2,434,080 shares worth $20.1M. The position accounts for 0.02% of the portfolio, ranked #907.

Steven Cohen first reported a position in EVMN in Q4 2025 and has held it in 4 quarters since. 102 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.

  • Steven Cohen held 2,434,080 shares of Evommune worth $20.1M as of Q3 2026.
  • Steven Cohen bought 999,031 Evommune shares in Q3 2026, an estimated $12M.
  • Evommune made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #907 holding.
  • Steven Cohen first reported a position in Evommune in Q4 2025 and has held it in 4 quarters since.
  • 102 funds tracked by Wall St. Rank held Evommune as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.